Institut du Cerveau – ICM Research and Technology Office holds the core of industrial partnerships.
Incorporating industrial requirements at the earliest of a therapeutic or diagnosis project sets its best chance of success. This is why the team is here, to bridge the gap between the expertise and innovations of Institut du Cerveau – ICM academics and the needs of industry, in neuroscience care and diagnosis but also in wider applications.
A vibrant team of a ten of executives takes care of 4 main missions:
- Scouting promising projects among lab benches to promote patenting from the researchers and assist through the patent deposition process;
- Out licensing of Institut du Cerveau – ICM patent portfolio to young companies and larger corporations;
- Providing support to Institut du Cerveau – ICM’s spinoffs and young startup collaborating with Institut du Cerveau – ICM academics through the iPEPS startup incubator;
- Design, set up and sustain ambitious and long term alliances so that the transfer from bench to bedside can be the most efficient possible.
Looking for Licencing-in? Institut du Cerveau – ICM holds patents in the areas of:
- Glioma diagnosis
- Parkinson disease
- Neurodegenerative diseases
- Sleep and memory
- Dopamineragil related disorders
- Immune approaches for Alzheimer’s disease
- Cerebellar impairments
- Huntington disease
Alexis Génin heads the Research & Technology Development office at Institut du Cerveau, since 2010. He holds a PhD in neurosciences. After a research assignment in Asia and collaborative programs with the pharmaceutical industry, he took responsibility of international business development operations for a Paris-based medtech & diagnostic company. Alexis participated to the establishment of INSERM-Transfert, a spin-off company from INSERM, in charge of Tech transfer, before joining the Institut du Cerveau at its start.
Valérie Fonteny is Office Manager, in charge of the administrative management of partnerships and patents, and of logistical and organizational issues. She holds a tourism technician’s certificate (national interpreter-guide) and an art history postgraduate diploma. She worked at the National Cancer Institute as an executive assistant, then as a project manager with the director of research. Previously, she worked at Orphanet, the portal of rare diseases and orphan drugs. Email
BIOTECH / DRUG DEVELOPMENT
Athanasia Liabotis is in charge of preclinical projects development. She holds a PhD in cell biology and physiology from Sorbonne University, which she achieved at the Collège de France in Paris. After a Specialized Master in pharmaceutical and biotechnology management at ESCP Europe Business School, she joined the Roche Institute as a scientific project manager.
Fanny Audibert is in charge of preclinical projects development. She holds a Master’s degree in Bio-Engineering and Innovation in Neurosciences from ESPCI and a Specialised Master in Biopharmaceutical Management from ESCP Europe Business School. Prior to joining the Institute, Fanny trained in Business Development with Theranexus; she also worked as a Healthtech Analyst at Bpifrance le Hub.
Benjamin François is a drug development engineer. Benjamin is in charge of preclinical testing of new drug candidates developed by research teams at Institut du Cerveau and a variety of medicinal chemists. He holds a Biotechnology Engineering diploma from EBI in Research and Development. He worked as a research engineer at the Atomic Energy Commission on Prion diseases, and had a second experience in a private CRO as a preclinical test engineer.
MEDTECH / LIVING LAB
Romain Gombert is the Medtech Development Manager and manages Institut du Cerveau’s livinglab, CARE LAB. He graduated with one Master degree in mechatronics systems for rehabilitation at Pierre and Marie Curie University (UPMC Paris) and Università degli Studi di Brescia (UNIBS – Italy) and a second in management of technologies and innovation at Paris Dauphine and Mines ParisTech. He built his expertise in innovative project management across the Living-Lab LUSAGE at Broca hospital and several Innovation Labs in Europe.
Pierre Tissier is a prototyping engineer at the Institut du Cerveau. He designs and produces technologies for research purposes and for patient care. He also provides access to the latest prototyping technologies (3D printers, laser cutting machine…) to researchers and industry partners. Pierre holds a Master degree in robotic engineering from the mechanical engineering school SupMeca.
Sarah Benessiano is in charge of project development at the Institut du Cerveau’s LivingLab. She assists healthcare professionals in the definition, implementation and development of their innovation projects, with the support of design and engineering students. She holds a Master’s degree in Product and UX Design from Strate school of design and an engineering bachelor from the IUT of Cachan.
David Patole works as innovation engineer at Institut du Cerveau’s LivingLab, where he is in charge of human centered projects, user research and co design. He holds an advanced technician’s certificate in graphic design, a professional certification in project management and a Master’s degree in UX design. He worked as engineer for Airbus cockpit and as design consultant, to finally join the medical community.
Julien Elric is the iPEPS-Institut du Cerveau incubator manager. His activities at Institut du Cerveau range from providing support for startups development to fostering international innovation and entrepreneurship. He holds a PhD in cell biology from Institut Pasteur. After graduating from INSEAD, he joined the business development and licensing department at Institut Curie, in charge of international development. Email
Louise Remigereau is in charge of logistical and organizational aspects of the iPEPS incubator. She holds a bachelor in communication and a master’s degree in event management. She has always worked in connection with small- and medium-size companies.
Alexis Auvitu is a deeptech startups manager on the iPEPS incubator. His missions are: management of a corporate acceleration program for startups, intrapreneurship program creation, animation and support of startups on the iPEPS ecosystem. He has a dual degree in pharmaceuticals and business with an advanced master in biotechnology management. Alexis has been working for three years in health innovation in different structures: biocluster in health, a private research institute, or a digital business unit in the pharmaceutical industry.
Camille Dorra is Medtech and Artificial Intelligence manager for the iPEPS incubator. Her missions aim at supporting the Startups of the “Chevaleret” campus through several programs. She has a dual background in biology and entrepreneurship. Camille has been working for more than 4 years with startups in the health sector: after an experience in a financial consulting firm, she joined a health incubator and supported more than 40 startups in the sector.
Lea Mekies is Digital Health project manager for the iPEPS incubator. She is in charge of supporting digital health startups at Station F and the Janssen Digital Solutions QuickFire Challenge acceleration program. She has a Master 2 degree in entrepreneurship and innovative projects. After her academic training at ESSEC, she joined Business France where she was in charge of the internationalization of French startups. Email
ENTREPRENEURS IN RESIDENCE & MENTORS
Damien Salauze is entrepreneur in residence at IPEPS-Institut du Cerveau. He holds a PharmD, PhD, as well as an MBA from INSEAD. He first worked at Rhône-Poulenc / Aventis in drug-development position and marketing positions, and then joined the venture-capital firm Auriga Partners. He there became CEO of 2 start-up companies: Novagali Pharma then Sepal Pharma. He also headed the Office of technology Transfer at Institut Curie. Damien serves as equity manager for Institut du Cerveau (in addition to heading of the FINDMED consortium, coordinated by Institut du Cerveau).
Ségolène Aymé is rare disease expert in residence at Institut du Cerveau, as Emeritus director of Research at INSERM. She was a medical geneticist and epidemiologist. She founded Orphanet and the Orphanet Journal of Rare Diseases. She held several international positions in the field of rare diseases and orphan drugs research and policy. Ségolène contributes to the development of the Institut du Cerveau activities in favor of the rare neurological diseases.